LDL Cholesterol: Optimal Numbers, High Numbers, and How to Read Yours
LDL is the "bad" cholesterol only if you leave the story there. Understand optimal targets by risk group, the ApoB perspective, and the interventions that actually shift the number.
For most healthy adults an LDL below 100 mg/dL (2.6 mmol/L) is optimal. For anyone with existing cardiovascular disease, diabetes, or familial hypercholesterolaemia, the target drops to below 70 mg/dL (1.8 mmol/L) — and in very high-risk patients, below 55 mg/dL. LDL is causal for atherosclerosis, but ApoB and lipoprotein(a) refine the risk picture.
LDL cholesterol is a causal driver of atherosclerotic cardiovascular disease — every 1 mmol/L (~39 mg/dL) reduction cuts major cardiovascular events by ~22%. Optimal LDL depends on absolute cardiovascular risk: < 100 mg/dL for low-risk adults, < 70 for high-risk, < 55 for secondary prevention or very-high-risk primary prevention. ApoB, which counts every atherogenic particle, is a stronger predictor of risk than LDL-C when the two disagree. Lifestyle (Mediterranean diet, saturated-fat reduction, weight loss, exercise) drops LDL 10–20%; statins drop it 30–55%; PCSK9 inhibitors drop it another 50–65% on top of statins.
- Optimal LDL (low risk)
- < 100 mg/dL (< 2.6 mmol/L)
- High CV risk target
- < 70 mg/dL (< 1.8 mmol/L)
- Secondary prevention target
- < 55 mg/dL (< 1.4 mmol/L)
- Best next-line marker
- ApoB
- Fasting required
- Only for accurate triglycerides
What LDL is and why it matters
Low-density lipoprotein carries cholesterol from the liver to peripheral tissues. Every LDL particle that gets stuck in an arterial wall is a nucleation point for a plaque. Genetic experiments (Mendelian randomisation), decades of clinical trials, and pathology studies all point in the same direction: LDL is causal for atherosclerosis. The dose is cumulative — decades of a moderately high LDL do more damage than a few years of a very high LDL.
Because it is causal, LDL is treated proactively. The 2019 ESC/EAS guidelines and 2018 ACC/AHA cholesterol guidelines both moved the target lower and lower, especially in high-risk patients. "Lower is better, earlier is better, longer is better" is now the operating rule.
LDL targets by cardiovascular risk category
| Risk category | LDL target (mg/dL) | LDL target (mmol/L) | Typical examples |
|---|---|---|---|
| Low risk | < 116 | < 3.0 | Young adult, no risk factors, 10-yr risk < 5% |
| Moderate risk | < 100 | < 2.6 | One or two risk factors, 10-yr risk 5–10% |
| High risk | < 70 | < 1.8 | Diabetes, CKD stage 3, 10-yr risk 10–20% |
| Very high risk | < 55 | < 1.4 | Established ASCVD, recurrent event, familial hypercholesterolaemia |
Reading a standard lipid panel
A standard fasting or non-fasting lipid panel reports total cholesterol, LDL, HDL, and triglycerides. LDL is usually calculated (Friedewald or Martin-Hopkins equations) rather than measured directly — the calculation becomes unreliable when triglycerides exceed ~400 mg/dL, at which point a direct LDL, non-HDL cholesterol, or ApoB should be used.
Non-HDL cholesterol (total minus HDL) captures every atherogenic particle in one number and is not sensitive to fasting or triglycerides. Non-HDL targets are approximately 30 mg/dL higher than the equivalent LDL target (e.g. LDL < 70 ≈ non-HDL < 100).
Why ApoB may be more accurate
Each LDL, VLDL, and IDL particle carries exactly one ApoB protein. Measuring ApoB therefore counts every atherogenic particle regardless of its cholesterol content. In patients with high triglycerides, metabolic syndrome, or type 2 diabetes, LDL-C can look reassuring while ApoB is elevated because the particles are small and dense. In these situations ApoB predicts events more accurately than LDL-C.
The National Lipid Association and the Canadian Cardiovascular Society now list ApoB as an equally valid — and in some patients, preferred — primary treatment target. ApoB below 80 mg/dL is generally optimal; below 65 for high-risk and below 50 for secondary prevention.
What lowers LDL and by how much
Realistic effect sizes for a person willing to make the change: reducing saturated fat below 7% of calories drops LDL by roughly 10–15%; a Portfolio/Mediterranean diet with soluble fibre, nuts, plant stanols, and soy protein drops LDL by 20–30%; 5–10% weight loss drops LDL by 5–15%; regular aerobic exercise adds another 5–7%.
On the medication side: moderate-intensity statins drop LDL by 30–50%; high-intensity statins by 45–60%; ezetimibe adds another 15–20%; bempedoic acid adds 15–25%; PCSK9 inhibitors and inclisiran add 50–65% on top of a statin. Combination therapy is often needed to hit modern targets — expect statin + ezetimibe as the standard high-risk pairing.
- LDL > 190 mg/dL (4.9 mmol/L) with a family history of early heart attack — screen for familial hypercholesterolaemia.
- You have already had a heart attack, stroke, or coronary revascularisation and LDL is above 70 mg/dL.
- You have diabetes plus one additional risk factor and LDL is above 100 mg/dL.
- Lipoprotein(a) has never been measured — it should be checked at least once in a lifetime.
LDL next-step decision tree
- 1LDL between 100 and 189, no CV disease?Calculate a 10-year cardiovascular risk score (ACC/AHA, QRISK3, or SCORE2). If risk ≥ 7.5%, statin discussion is warranted; if ≥ 20%, statin is strongly recommended.
- 2LDL ≥ 190 mg/dL?Screen for familial hypercholesterolaemia (family history, physical exam, genetic testing). Start high-intensity statin regardless of other risk factors.
- 3Already have CV disease?High-intensity statin + ezetimibe. Aim for LDL < 55 mg/dL. Add PCSK9 inhibitor or inclisiran if target unmet.
- 4On maximum statin but LDL still above target?Add ezetimibe. Then bempedoic acid or PCSK9 inhibitor. Check Lp(a) once — it changes the treatment picture.
Related questions people ask
- Is LDL 130 really high?
- What is the difference between LDL and ApoB?
- Can diet alone lower LDL below 100?
- Do I need a statin?
- What is Lp(a) and should I test it?
- How do blood pressure and LDL together affect risk?
- Should hs-CRP be checked alongside LDL?
Frequently asked questions
- LDL is causal for atherosclerosis — lower is better, earlier is better, longer is better.
- Optimal LDL depends on cardiovascular risk category (< 100 low-risk, < 70 high-risk, < 55 very high risk).
- ApoB is a stronger predictor when LDL-C and triglycerides disagree.
- Lifestyle drops LDL 10–30%; statins 30–55%; PCSK9 inhibitors + statin > 70%.
- Lipoprotein(a) should be measured at least once in a lifetime.
- Non-fasting samples are acceptable for LDL, HDL, and non-HDL.
References
3 sources- AHACholesterol Guidelines
Patient-facing cholesterol resource.
heart.org
- ESC/EAS 2019 Guidelines for the Management of Dyslipidaemias
European targets by risk category.
academic.oup.com
- National Lipid AssociationApoB Position Statement
Rationale for ApoB targeting.
lipid.org
Related articles
Laboratory TestsTSH Test: Normal Range, High, Low & What Your Result Actually Means
TSH is the single most important thyroid number. Understand normal ranges by age and pregnancy, what a high or low value really tells you, and the two follow-up tests that clinch the diagnosis.
Laboratory TestsHbA1c Test: Normal Range, Prediabetic, Diabetic Cut-offs & How to Lower It
HbA1c reflects your average blood sugar over ~3 months. Understand every threshold — normal, prediabetes, diabetes — and the realistic actions that move the number.
Laboratory TestsCreatinine and eGFR: How to Read Your Kidney Function Blood Test
Creatinine and eGFR together tell you how well your kidneys are filtering. Learn what each number means, why muscle mass and race adjustments matter, and when a low eGFR is genuinely concerning.